Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study

Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Helene Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda DiMeglio, R. Paul Wadwa, Andrew J. Ahmann, Michael J. Haller, Brandon M. Nathan, Santica M. Marcovina, Emmanouil Rampakakis, Linyan Meng, Roy W. Beck

Research output: Contribution to journalLetter

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)e193-e194
JournalDiabetes Care
Volume39
Issue number10
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Rickels, M. R., Ruedy, K. J., Foster, N. C., Piché, C. A., Dulude, H., Sherr, J. L., Tamborlane, W. V., Bethin, K. E., DiMeglio, L., Wadwa, R. P., Ahmann, A. J., Haller, M. J., Nathan, B. M., Marcovina, S. M., Rampakakis, E., Meng, L., & Beck, R. W. (2016). Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study. Diabetes Care, 39(10), e193-e194. https://doi.org/10.2337/dci16-0025